Endovascular treatment for posterior epistaxis: should it still be considered a last-resort option? A literature review - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Reassessing Endovascular Therapy for Posterior Epistaxis: Is It Time to Move Beyond the Last-Resort Label? A Review of Current Literature

  • By

  • Hector R. Martinez

  • Daniel F. Aguilera-Maldonado

  • Andrea Paola Sanchez-Cantu

  • Patricia Maria Orviz-Ortiz

  • Oscar I. Paz-Sanchez

  • Nerea Martin del Campo

  • Carlos Cuilty-Siller

  • Karla Santos-Santillan

  • Jorge Arechavaleta Santos

  • Oscar Gutierrez Trevino

  • Beatriz Elena Perez-Martinez

  • Jose A. Figueroa-Sanchez

  • April 7, 2026

Share

Objective:

To provide a comprehensive overview of posterior epistaxis, focusing on its vascular anatomy and the role of endovascular treatment, emphasizing its impact on treatment outcomes.

Approach:
    Key Findings:
    • Posterior epistaxis is challenging due to variable etiologies and complex vascular anatomy.
    • Endovascular treatment is feasible and safe, requiring thorough angiographic assessment prior to intervention.
    • Current guidelines still classify endovascular therapy as a last-resort option, which may hinder timely intervention.
    Interpretation:

    Endovascular therapy should be reconsidered as a viable option for posterior epistaxis rather than being reserved for intractable cases, given its effectiveness and safety profile supported by recent studies.

    Limitations:
    • The review is based on existing literature, which may have inherent biases.
    • Variability in clinical practice and guidelines may affect the generalizability of findings, and publication bias may influence the perceived effectiveness of treatments.
    Conclusion:

    A comprehensive approach, including angiography, can enhance treatment outcomes for posterior epistaxis, and endovascular therapy should be more widely accepted as a primary treatment option, necessitating a shift in clinical guidelines.

Original Source(s)

Related Content